SC questions centre over medicine markups citing ₹15 to ₹250 price gap

Supreme Court questioned Centre over massive gaps between medicine retail prices and wholesale purchase costs.
The bench criticised current price regulation, describing National Pharmaceutical Pricing Authority as appearing totally defunct.
The court highlighted extreme overpricing, citing drip lines bought for ₹15 but sold to patients for ₹250.
The court challenged excessive hospital markups on essential medicines while reserving its order on pricing regulation.

Get 100 stories a day on the app Read, watch & listen · Free on iOS & Android

Newer